solar lentigines
These are relatively well-defined pigmented spots associated with cumulative ultraviolet exposure. The treatment area and settings determine whether full-face or spot treatment is appropriate.
Customized Skin Treatment
Dullness or uneven tone may reflect overlapping solar lentigines, freckles, melasma, post-inflammatory hyperpigmentation and redness. At our clinic in Motomachi, Kobe, we assess color, depth, distribution and skin response, then plan a suitable combination of laser treatment, transdermal delivery and topical or oral medication.

Even if it looks the same "brown",Treatment is not one-size-fits-all.
You can contact us from the stage of "I want to treat these spots, but I don't know what to choose".
The number of fine spots on my cheeks is increasing
My complexion looks dull or uneven
I want to treat widespread freckles
I want targeted treatment for defined dark spots
There is diffuse pigmentation across both cheeks
Pigmented spots and redness appear together
I am worried pigmentation may darken after treatment
I also want to consult about topical medication and home care
When melasma and inflammation coexist, excessive irritation can worsen pigmentation. During consultation, we assess the current condition and sequence targeted treatment and skin-conditioning care.
Similar-looking pigmentation may require a different approach depending on pigment depth and whether inflammation is present.
These are relatively well-defined pigmented spots associated with cumulative ultraviolet exposure. The treatment area and settings determine whether full-face or spot treatment is appropriate.
Freckles often appear as fine pigmented spots across the nose and cheeks. A carefully selected full-face treatment may be considered.
It often appears as diffuse, symmetrical pigmentation on the cheeks and may fluctuate with irritation or inflammation. Treatment is planned with stabilization as the first priority.
These lesions may appear blue-gray because pigment lies deeper in the dermis. A course of physician-administered treatment may be required.
Pigmentation may remain after acne, friction, burns or other inflammation. Avoiding further irritation is important; topical medication and observation over time may be considered.

Direct English rendering of the Japanese text in the retained source image, in visual reading order (top to bottom and left to right within each row; Before/After panels and arrows remain in the image): Melasma and discrete pigmented spots develop differently and can coexist on the cheeks, so treatment is selected after assessing the skin. Melasma is associated with chronic inflammation leading to pigmentation and can be influenced by friction, hormones, and UV exposure. Discrete spots such as solar lentigines are associated with photoaging and reduced pigment clearance after years of UV damage. The arrowed comparison converges on the cheeks, where both conditions commonly coexist; because appearance alone may not distinguish them, careful diagnosis is required.
At our clinic, we do not select a device in advance. We first assess borders, asymmetry, color depth, redness, dryness and previous treatment responses. We also consider your preferred degree of change and acceptable downtime.
We assess targeted and full-face treatment as distinct options.
Stabilizing inflammation or irritation may take priority.
Settings are reassessed according to redness, dryness and changes in tone.
Treatment may involve more than one method, selected for distinct goals.

The 694 nm ruby laser delivers energy in a fractional pattern of fine microbeams. We will consider low-power full face irradiation for fine spots, freckles, and color variations on the full face, and physician-administered spot treatment for dark spots and ADMs.

ADVATx may be considered when pigmentation coexists with redness, visible vessels, sebum or chronic inflammation. When redness accompanies melasma, addressing inflammation and the skin condition first may be appropriate.

POTENZA may be considered when melasma is the primary concern and a staged, skin-responsive approach is appropriate. It may be combined with peeling or topical and oral medication, with treatment staged to minimize irritation.

When dryness or irritation is pronounced, stabilizing the skin comes first. Options include Mesona J transdermal delivery, topical or oral medication, gentle cleansing, moisturizing and sun protection.
| Status | Potential options | Treatment role | downtime |
|---|---|---|---|
| Fine spots/dullness | fractional ruby laser treatment | A course of low-fluence full-face treatment | Usually limited |
| Dark localized pigmented spots | Physician-administered spot treatment | Target defined lesions | Crusting; protective dressing may be required |
| melasma | Topical/oral medication/POTENZA/Mesona J | Stabilize the skin and reduce irritation | Depends on treatment |
| Reddish tones | ADVATx | Address vascular redness and inflammation | Usually limited |
We assess borders, pigment depth, redness, skin texture and treatment history as well as color. If a procedure is not appropriate, we recommend another option without rushing into laser treatment.

Treatment for dark spots and treatment for dullness, redness, and dryness throughout the face have different roles. We separate these goals and plan them in a suitable order.

Sun protection, moisturizing and avoiding friction are also part of treatment. We review each response and adjust settings, intervals and home care.

These are representative fees for fractional ruby laser treatment. Prices shown include tax.
Examination fees, anesthesia, protective materials, topical medications, cosmetics, etc. may be required separately. See the current price list for ADVATx, POTENZA, Mesona J and prescription medication fees.
Remove makeup, check color, boundaries, distribution, redness, dryness, sunburn, and treatment history.
We explain the proposed sequence and likely number of treatments based on the type of pigmentation and acceptable downtime.
Treatment may include laser therapy, transdermal delivery or topical medication, selected according to the skin condition that day.
Continue sun protection and moisturizing. At review, we adjust settings, intervals and combinations according to the response.
You may experience redness, flushing, dryness, tingling, and spotted scabs.
Pain, redness, swelling, scabs, and post-inflammatory pigmentation may occur and protective tape may be required.
Possible adverse effects include rash, blistering, burns, hyperpigmentation, hypopigmentation, scarring or worsening symptoms.
Avoid strong sunburn, friction, and forced peeling of scabs, and continue moisturizing and sun protection.
Treatment may be postponed or modified during pregnancy or breastfeeding, or with recent sunburn, dermatitis, infection, photosensitizing medication, relevant illness or a previous adverse laser reaction.
Options differ for defined spots, diffuse uneven tone, melasma and redness. We select treatment after assessing color, distribution, redness and treatment history.
Spot treatment may be considered for localized lesions, while diffuse uneven tone or melasma may require a staged course. The number of treatments depends on the type and response.
Because irritation can worsen melasma, laser candidacy requires careful assessment. Topical or oral medication, Mesona J, POTENZA or ADVATx may take priority, with fractional ruby laser treatment considered only when appropriate.
Makeup may be possible on the same day after low-fluence full-face or transdermal delivery treatment if the skin is stable. Spot irradiation requires attention to protective tape and scabs.
New pigmentation or uneven tone can develop with ultraviolet exposure, friction and aging. Continue sun protection, moisturizing, friction avoidance and maintenance when needed.
Yes. We assess defined dark spots separately from diffuse dullness, uneven tone, redness and dryness, then plan targeted and skin-conditioning treatments.
You are welcome to consult us if you are unsure whether you have melasma or which approach suits your pigmentation. We discuss your goals and acceptable downtime, assess candidacy and may recommend delaying laser treatment.
